Infused with Magnolia Liliflora Flower, Angelica Keiskei Leaf/Stem Extract, and Centella Asiatica to calm irritation, deeply nourish the skin, and promote natural regeneration and improved elasticity
Studied for effects on microcirculation in injured or photo-aged tissue
The May 14 GHK-Cu update and the April 30 GLP-1 proposal are separate policy actions, but they read together as one signal: FDA is actively curating both lists, and the regulatory ceiling for peptide compounding is being lowered for some substances and held for others
Because the formulation is delivered directly into the bloodstream, it bypasses the digestive system entirely and this matters
Monitoring Recommendations For extended use protocols, periodic laboratory monitoring adds an extra layer of safety
Although peptides like BPC 157 are not yet FDA-approved, we are seeing promising results in patients seeking relief from a variety of injuries, chronic pain, and inflammation